- Home
- CNXC vs XENE Comparison
CNXC vs XENE Comparison
Compare CNXC & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNXC
- XENE
- Stock Information
- Founded
- CNXC 1991
- XENE 1996
- Country
- CNXC United States
- XENE Canada
- Employees
- CNXC N/A
- XENE N/A
- Industry
- CNXC Computer Software: Prepackaged Software
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- CNXC Technology
- XENE Health Care
- Exchange
- CNXC Nasdaq
- XENE Nasdaq
- Market Cap
- CNXC 3.6B
- XENE 2.9B
- IPO Year
- CNXC N/A
- XENE 2014
- Fundamental
- Price
- CNXC $47.94
- XENE $40.38
- Analyst Decision
- CNXC Strong Buy
- XENE Strong Buy
- Analyst Count
- CNXC 5
- XENE 11
- Target Price
- CNXC $69.00
- XENE $52.73
- AVG Volume (30 Days)
- CNXC 1.1M
- XENE 739.7K
- Earning Date
- CNXC 09-25-2025
- XENE 11-11-2025
- Dividend Yield
- CNXC 3.00%
- XENE N/A
- EPS Growth
- CNXC 54.10
- XENE N/A
- EPS
- CNXC 4.74
- XENE N/A
- Revenue
- CNXC $9,720,870,000.00
- XENE $7,500,000.00
- Revenue This Year
- CNXC $3.62
- XENE N/A
- Revenue Next Year
- CNXC $3.16
- XENE $207.88
- P/E Ratio
- CNXC $10.13
- XENE N/A
- Revenue Growth
- CNXC 3.40
- XENE N/A
- 52 Week Low
- CNXC $36.28
- XENE $26.74
- 52 Week High
- CNXC $66.00
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- CNXC 41.04
- XENE 63.78
- Support Level
- CNXC $46.47
- XENE $38.49
- Resistance Level
- CNXC $49.37
- XENE $40.17
- Average True Range (ATR)
- CNXC 2.23
- XENE 1.33
- MACD
- CNXC -0.45
- XENE 0.11
- Stochastic Oscillator
- CNXC 36.64
- XENE 100.00
About CNXC Concentrix Corporation
Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.